Skip to content

Effect of low-intensity laser therapy of myofascial pain syndrome of trapezius:a randomized, double-blind, placebo-controlled clinical trial

Research on real-time meridian monitoring,the auxiliary diagnosis system and acupuncture treatment equipment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008361
Enrollment
Unknown
Registered
2016-04-26
Start date
2016-04-28
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain syndrome

Interventions

635nm:635nm CW laser irradiation
808nm:808nm CW laser irradiation
alternate:Alternating 635nm and 808nm irradiation
control group:none

Sponsors

Institute of Biomedical Engineering,Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) met the diagnostic criteria of MPS, and the pain in the neck; (2) in the past 6 months have cervical chronic pain or acute pain in nearly 3 months; (3) under the age of 65 years; (4) voluntarily accept and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) have received drug injection for Mtrps of the trapezius in last 3 months; (2) muscle or bone related with MTrPs of trapezius suffered trauma or surgery in last year; (3) MTrPs site of trapezius have skin lesion, infection or inflammatory edema; (4) with fibromyalgia, radiculopathy or spinal cord lesions, severe peripheral neuropathy or systemic organic lesion(such as diabetes, etc.); (5) mental illness, alcoholism, drug addiction or are using drugs that affect the nervous system (such as sedative drugs, antidepressants, etc.); (6) over the past 30 days use any drug test; (7) also participate in other research; (8) laser irradiation therapy in the past subjects blinded; (9) someone who are allergic to laser irradiation, such as itching, swelling, and rash; (10) can not complete a variety of scale; (11) do not want to be randomly grouped; (12) the researchers think that there are other reasons can not be selected.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale;stiffness;

Secondary

MeasureTime frame
SF-36;cervical active ROM;The Neck Disability Index;

Countries

China

Contacts

Public ContactWu Jinpeng

Institute of Biomedical Engineering,Chinese Academy of Medical Sciences

microkn@126.com+86 13718609887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026